STERIS plc
STE Healthcare Medical Devices
STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025. In the quarter to June 2026, revenue grew 7.30%, EPS grew 13.9%, free cash flow fell 14.4% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.
Follow STE
STERIS plc (STE) P/E ratio
As of 16 October 2026, STERIS plc (STE) trades at a P/E ratio of 27.1×. Over the past ten years it has ranged from 0.0× (March 2023) to 203× (June 2023); the current reading is higher than 7% of that period. That is above the Medical Devices industry median of 23.2× and above the Healthcare sector median of 23.0×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2026 | 27.8× | (23.64%) |
| FY2025 | 36.4× | (36.96%) |
| FY2024 | 57.7× | (67.11%) |
| FY2023 | 175× | 75.65% |
| FY2022 | 99.9× | 143.36% |
| FY2021 | 41.1× | 41.07% |
| FY2020 | 29.1× | (17.56%) |
| FY2019 | 35.3× | 33.02% |
| FY2018 | 26.5× | (51.10%) |
| FY2017 | 54.3× | 13.80% |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 25.6× | (7.68%) |
| Mar 2026 | 27.8× | (21.21%) |
| Dec 2025 | 35.3× | (0.39%) |
| Sep 2025 | 35.4× | (3.33%) |
| 42 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| GEHC GE HealthCare Technologies Inc. compare | 16.0× |
| PHG Koninklijke Philips N.V. compare | 18.8× |
| GMED Globus Medical, Inc. compare | 19.3× |
| ZBH Zimmer Biomet Holdings, Inc. compare | 23.0× |
| STE STERIS plc | 27.1× |
| DXCM DexCom, Inc. compare | 33.2× |
| SNN Smith & Nephew SNATS, Inc. compare | 35.4× |
| BIO.B Bio-Rad Laboratories, Inc. compare | 43.7× |
| PEN Penumbra, Inc. compare | 78.4× |
| Medical Devices industry median | 23.2× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on STE
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement